This study is a feasibility study to validate magnetizatin transfer (MT)-weighted balanced
steady state free precession (bSSFP) cine cardiac magnetic resonance (CMR) against current
clinical gold standard diagnostics, and to determine the applicability of MT-weighted bSSFP
cine CMR for diagnosis of fibrotic remodeling in chronic kidney disease (CKD5) patients.
Participants will not receive a study drug or placebo and will not be randomized. A total of
250 participants will be enrolled into this study.